Correlation Between Aldeyra and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aldeyra and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldeyra and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Aldeyra and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and Oramed Pharmaceuticals.
Diversification Opportunities for Aldeyra and Oramed Pharmaceuticals
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aldeyra and Oramed is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Aldeyra i.e., Aldeyra and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aldeyra and Oramed Pharmaceuticals
Given the investment horizon of 90 days Aldeyra is expected to under-perform the Oramed Pharmaceuticals. In addition to that, Aldeyra is 1.87 times more volatile than Oramed Pharmaceuticals. It trades about -0.12 of its total potential returns per unit of risk. Oramed Pharmaceuticals is currently generating about 0.05 per unit of volatility. If you would invest 232.00 in Oramed Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 5.00 from holding Oramed Pharmaceuticals or generate 2.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aldeyra vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| Aldeyra |
| Oramed Pharmaceuticals |
Aldeyra and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aldeyra and Oramed Pharmaceuticals
The main advantage of trading using opposite Aldeyra and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.| Aldeyra vs. Tarsus Pharmaceuticals | Aldeyra vs. Travere Therapeutics | Aldeyra vs. Eton Pharmaceuticals | Aldeyra vs. Viridian Therapeutics |
| Oramed Pharmaceuticals vs. Protalix Biotherapeutics | Oramed Pharmaceuticals vs. Corvus Pharmaceuticals | Oramed Pharmaceuticals vs. Aldeyra | Oramed Pharmaceuticals vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |